Supplementary Figure S4 from Preclinical Investigation of 212Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model

Autor: Julien J. Torgue, Ebrahim S. Delpassand, Izabela Tworowska, Amal Saidi, Tania A. Rozgaja Stallons
Rok vydání: 2023
DOI: 10.1158/1535-7163.22510411.v1
Popis: Alpha imaging of tumors treated with 212Pb-DOTAMTATE showed homogenous distribution of the drug at all tumor sizes up to 1500mm3 (Panel B). Kidney protection agent consisting of 35mg lysine are effective at reducing kidney uptake of 212Pb-DOTAMTATE but do not have an impact on 212Pb-DOTAMTATE uptake by AR42J tumors (Panel B).
Databáze: OpenAIRE